Comparison of the Medication Adherence of Patients Treated With Telmisartan/Hydrochlorothiazide or Telmisartan/Amlodipine FDC Versus Double-pill Combination Therapy in Real-world Japanese Therapeutic Practice
Status: Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 10 Jul 2019
Price : $35 *
At a glance
- Drugs Amlodipine/telmisartan (Primary) ; Telmisartan/hydrochlorothiazide (Primary) ; Amlodipine; Telmisartan
- Indications Hypertension
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim
- 08 Jul 2019 Planned End Date changed from 29 Jul 2019 to 27 Jan 2020.
- 08 Jul 2019 Planned primary completion date changed from 29 Jul 2019 to 27 Jan 2020.
- 08 Jul 2019 Planned initiation date changed from 28 Jun 2019 to 23 Dec 2019.